Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1884798 | 0.98 | MAPK1 (0.32) | MAPK1HSD17B10TSHR | |
| SCHEMBL1886377 | 0.96 | MAPK1 (0.33) | MAPK1HSD17B10TSHR | |
| SCHEMBL1889510 | 0.93 | MAPK1 (0.37) | MAPK1HSD17B10TSHR | |
| SCHEMBL1889306 | 0.91 | — | — | |
| SCHEMBL1885865 | 0.83 | — | — | |
| SCHEMBL1881270 | 0.83 | MAPK1 (0.31) | MAPK1HSD17B10 | |
| SCHEMBL1882473 | 0.81 | — | — | |
| SCHEMBL1884830 | 0.78 | MAPK1 (0.33) | MAPK1HSD17B10TSHR | |
| SCHEMBL1890048 | 0.77 | KDM4E (0.32) | TSHR | |
| SCHEMBL1891819 | 0.77 | MAPK1 (0.32) | MAPK1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130320326-A1 | INSULATING MATERIAL FORMING COMPOSITION FOR ELECTRONIC DEVICES, INSULATING MATERIAL FOR ELECTRONIC DEVICES, ELECTRONIC DEVICES AND THIN FILM TRANSISTOR | IDEMITSU KOSAN CO., LTD. | 2013-12-05 | — | — | US | disclosed |
| US-7939682-B2 | Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-11 | — | — | US | disclosed |
| EP-1950190-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | TAS1R1, ADORA1, TAS2R1 | MAPK1 2489/4885HSD17B10 1350/4885TSHR 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.